What Does Anus Cancer Look Like? Signs & Symptoms

Anal cancer most often appears as a persistent, nodular, reddish or scaly mass at or near the anal opening that tends to bleed easily. Many people, though, never see anything visually abnormal at all. The first clues are usually felt rather than seen: rectal bleeding, a sense of pressure or fullness, pain, or itching that does not go away with the usual over-the-counter treatments. Because these symptoms overlap heavily with common conditions like hemorrhoids and anal fissures, anal cancer is frequently misdiagnosed for months, sometimes longer.

What the Lesion Actually Looks Like

When anal cancer does produce a visible change, the most common appearance is a firm, raised nodule near the anal verge or just inside the anal canal. It tends to be reddish or flesh-colored, sometimes with a scaly or ulcerated surface, and it bleeds when touched or during bowel movements. The lesion can also look like a thickened, irregular patch of skin rather than a distinct lump. Some tumors sit far enough inside the canal that they are invisible from the outside and can only be felt during a digital rectal exam or seen with a specialized scope.¹

Not every anal cancer forms a lump. Some begin as a flat, non-healing ulcer that resembles a stubborn sore. Others start as a subtle area of thickened, discolored skin around the anus. The visual presentation depends partly on where the tumor originates. Cancers at the anal margin (the outer edge of the anus, where skin is visible) are more likely to be spotted by the patient. Cancers higher in the anal canal, above the dentate line, are hidden from view and diagnosed later on average.

Early Symptoms That Come Before Anything Visible

For many people, anal cancer announces itself through sensation rather than appearance. The earliest symptoms tend to be nonspecific and easy to attribute to something benign. They include:

Bleeding: Small amounts of bright red blood on toilet paper or in the bowl, often the very first symptom noticed.
Pain or pressure: A feeling of fullness or persistent aching in the anorectal area that does not resolve.
Itching: Ongoing pruritus around the anus that does not respond to hygiene changes or topical creams.
Mucous discharge: A mucopurulent (mucus-and-pus) discharge from the anus, sometimes mistaken for leakage related to hemorrhoids.
Stool changes: Narrower stools, increased straining, or fewer bowel movements than usual.

Some patients feel a small, hard lump at the anal opening that they assume is a hemorrhoid. Others have no symptoms at all in the early stages, and the cancer is found incidentally during a routine exam or a procedure for something else entirely.¹

How Symptoms Shift as the Cancer Grows

One consistent finding in the research is that the number and severity of symptoms climb sharply as the tumor advances. A retrospective study of 86 patients found that people with early-stage tumors reported an average of about two symptoms, while those with locally advanced disease reported more than four. Pain, constipation, abdominal discomfort, and weight loss were all significantly more common in advanced cases.²

Weight loss is a particularly telling sign that the disease has progressed. In that same study, it affected roughly 60 percent of patients with advanced tumors, compared with about 20 to 25 percent of those with earlier-stage disease.² Swollen lymph nodes in the groin are another red flag for spread. When anal cancer metastasizes regionally, it travels first to the inguinal lymph nodes, which you or your doctor may feel as firm, painless lumps in the crease where the thigh meets the pelvis. Imaging studies in advanced cases have shown enlarged, necrotic inguinal nodes and, in some patients, invasion into adjacent structures like the vaginal wall.¹

Systemic symptoms such as fatigue, nausea, insomnia, and appetite loss have been documented in treated anal cancer patients at rates higher than in healthy populations. While some of those symptoms are treatment-related, they can also be part of the disease itself in more advanced stages.³

Why Anal Cancer Gets Mistaken for Hemorrhoids and Fissures

This is where the story gets frustrating. The overlap between early anal cancer symptoms and garden-variety benign conditions is almost complete. Hemorrhoids cause bleeding, itching, and a feeling of a lump. Anal fissures cause pain, bleeding, and a visible sore. Anal cancer can cause all of the above. A case series documenting misdiagnosed anal cancers found that squamous cell carcinoma of the anus commonly presents with bleeding and pain, and that small or early tumors are “not uncommonly” misdiagnosed as hemorrhoids or idiopathic anal fissures.⁴

Several features should raise suspicion that something more than a benign condition is going on. An anal fissure that has not healed after eight to twelve weeks of proper treatment deserves a closer look. A fissure in an unusual position (most benign fissures sit along the posterior midline) is another warning sign. Hardened, thickened, or ulcerated skin tags around the anus can also point to cancer rather than a benign process. And any patient with known risk factors for anal cancer who presents with these symptoms warrants a biopsy rather than assumptions.⁴

One study of diagnostic delays found that while most patients sought medical attention relatively quickly, about one in five waited more than six months before seeing a doctor. And among all patients, 40 percent believed they themselves were responsible for the delay, often because they assumed their symptoms were caused by hemorrhoids.⁵ The embarrassment factor is real. Anal symptoms are among the most under-reported complaints in medicine, and the reluctance to discuss them compounds the diagnostic lag.

Rare Types That Look Different

The vast majority of anal cancers are squamous cell carcinomas, and the descriptions above apply mainly to them. But a few less common subtypes deserve mention because they present differently and can be even harder to recognize.

Anorectal melanoma is rare but aggressive. Unlike the flat or scaly appearance of squamous cell carcinoma, anorectal melanoma is almost always nodular. A systematic review found that the tumor appeared as a nodule in over 98 percent of cases. Bleeding was the most commonly reported symptom, occurring in about 85 percent of patients, followed by pain in roughly 69 percent and changes in bowel habits in about 29 percent.⁶ Melanomas in this area can be pigmented (dark brown or black) or amelanotic (flesh-colored or pink), which makes the amelanotic ones especially tricky. A flesh-colored nodule near the anus does not immediately suggest melanoma to most clinicians, contributing to delays.

Anal adenocarcinoma is another uncommon variant. One documented case involved a woman who experienced two years of perianal moisture, itching, and rectal bleeding before being correctly diagnosed. She had been repeatedly told she had hemorrhoids. The adenocarcinoma in her case was associated with perianal Paget’s disease, which can appear as a red, eczema-like rash around the anus, sometimes weeping or crusted.⁷ Perianal Paget’s disease itself looks like a chronic skin condition, another reason it gets missed for so long.

Precancerous Changes and What to Watch For

Anal cancer does not usually appear out of nowhere. It typically develops from precancerous changes known as anal intraepithelial neoplasia, or AIN. These precancerous lesions are caused by persistent infection with certain strains of human papillomavirus (HPV), particularly HPV 16 and 18. AIN lesions are graded as low-grade or high-grade, and high-grade lesions carry a real risk of progressing to invasive cancer over time.⁸

Here is the catch: AIN is invisible to the naked eye in most cases. It does not cause symptoms. It cannot be felt during a digital exam. It can only be identified through cytology (an anal Pap smear), biopsy, or a specialized procedure called high-resolution anoscopy, where the clinician applies acetic acid to the anal canal and examines it under magnification to highlight abnormal tissue.⁹ This means people at elevated risk for anal cancer cannot rely on visible changes or symptoms to catch the disease early. Screening, where available, matters.

Who Faces a Higher Risk

The single largest risk factor is HPV infection, which accounts for the overwhelming majority of anal squamous cell carcinomas. Within that broad category, certain groups face dramatically elevated risk. People living with HIV are roughly 28 times more likely than the general population to be diagnosed with anal cancer, due to both higher rates of HPV infection and the immune suppression that allows HPV-related precancerous changes to progress more readily.¹⁰ Screening HIV-positive individuals for anal cancer precursor lesions has been recommended on the basis that earlier detection and treatment of high-grade AIN may reduce the incidence of invasive cancer.¹¹

Other groups at increased risk include men who have sex with men (regardless of HIV status), people with a history of other HPV-related cancers such as cervical or vulvar cancer, organ transplant recipients on long-term immunosuppressive drugs, and people with a history of chronic inflammatory conditions of the anus. Smoking also elevates risk independently of HPV status.

For people in high-risk groups, the message about symptoms carries extra weight. A lump, bleeding, or persistent itching that might reasonably be shrugged off as hemorrhoids in the general population warrants prompt clinical evaluation and, when appropriate, a biopsy.

How the Diagnosis Happens

When anal cancer is suspected, the first step is usually a digital anorectal exam. The clinician inserts a lubricated, gloved finger into the anal canal and carefully feels for masses, thickened areas, or irregularities along the entire canal and surrounding tissue.⁹ It is a simple, low-tech exam, but it remains one of the most reliable first-pass methods for detecting palpable anal tumors. Any suspicious finding is followed by a biopsy.

Once a biopsy confirms cancer, imaging is needed to determine how far it extends. High-resolution MRI of the pelvis is the preferred tool for local staging because it can map the tumor’s exact size and position relative to the sphincter muscles and nearby organs like the bladder, prostate, or vagina.¹² CT scans are used alongside MRI to check for spread to lymph nodes and distant sites. PET-CT, which combines metabolic imaging with anatomical imaging, has become increasingly important for detecting small metastases that might be missed on standard CT alone.

None of these imaging tools replace the biopsy. A tumor can look suspicious on a scan, but the tissue must be examined under a microscope to confirm the cancer type, because the treatment for squamous cell carcinoma, adenocarcinoma, and melanoma of the anus differs substantially.

When a Symptom Needs Urgent Attention

Not every episode of rectal bleeding or anal itching is cancer. In fact, most of the time it is not. Hemorrhoids are extremely common and cause many of the same symptoms. But certain patterns should prompt you to see a doctor sooner rather than later:

Bleeding that persists: If rectal bleeding lasts more than a couple of weeks or keeps coming back despite treating presumed hemorrhoids, get it evaluated.
A lump that does not go away: Hemorrhoids often swell and shrink. A firm, fixed lump at or near the anus that stays the same or grows over weeks needs a clinical exam.
A sore that won’t heal: Any ulcer, crack, or wound near the anus that has not healed after several weeks of appropriate care, particularly if it is in an unusual location, should be biopsied.
New fecal incontinence: Losing control of bowel function can indicate that a mass is interfering with sphincter function. Research has shown that new-onset fecal incontinence can be an early presentation of colorectal and anal malignancies.¹³
Swollen groin lymph nodes: A hard, painless lump in the groin that appears alongside anal symptoms is a red flag for regional spread.

The embarrassment barrier is real and documented. If you find yourself putting off a visit because the location of the symptoms feels uncomfortable to discuss, consider that the delay itself is one of the most modifiable risk factors for a worse outcome. Clinicians examine this area routinely. For them, this is an unremarkable part of the job.

Perianal Skin Changes That Are Easy to Overlook

One presentation that gets almost no public awareness is the chronic skin-change pattern. Some anal cancers and their precursors announce themselves as persistent changes to the perianal skin rather than as a discrete lump or ulcer. These can include a patch of skin that appears thickened, whitened, or reddened, sometimes with a velvety or eczematous texture. In cases associated with perianal Paget’s disease, the skin around the anus may look inflamed and weepy for months or even years before anyone considers a biopsy.⁷

These changes are often treated empirically as dermatitis, fungal infection, or contact irritation. When the first-line treatments fail and the skin changes keep coming back, the next step should be a punch biopsy of the affected area. The problem is that this escalation does not always happen quickly. Both patients and clinicians tend to cycle through multiple topical treatments before considering that a persistent perianal skin condition could be malignant. If you have a patch of perianal skin that has been red, itchy, or irritated for more than a few months and has not responded to treatment, asking about a biopsy is reasonable.

The Role of HPV Vaccination

Because HPV drives the vast majority of anal squamous cell carcinomas, the HPV vaccine represents the most powerful upstream prevention tool available. The vaccine targets the high-risk HPV strains most commonly linked to anal cancer. It is most effective when given before exposure to the virus, which is why routine vaccination is recommended in adolescence. However, catch-up vaccination is approved for adults through age 26 in most guidelines, and in some cases up to age 45 after shared clinical decision-making with a provider.

Vaccination does not help someone who already has a persistent HPV infection in the anal canal, and it does not treat existing precancerous lesions. But at the population level, widespread HPV vaccination is expected to reduce anal cancer incidence substantially over the coming decades, just as it is already beginning to reduce rates of cervical cancer. For adults past the vaccination window who are in high-risk groups, screening with anal cytology and high-resolution anoscopy offers an alternative path to catching precancerous changes before they progress.⁸

1
Ovid / Nursing Made Incredibly Easy. Management of anal cancer
2
PubMed Central. Presenting symptoms predict local staging of anal cancer: a retrospective analysis of 86 patients
3
PubMed. Quality of life in patients treated for anal carcinoma-a systematic literature review
4
PubMed Central. A Case Series of Anal Carcinoma Misdiagnosed as Idiopathic Chronic Anal Fissure
5
PubMed Central. Reasons for delays in diagnosis of anal cancer and the effect on patient satisfaction
6
PubMed Central. Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma
7
PubMed Central. Anal adenocarcinoma with perianal Paget’s disease: A case report
8
PubMed Central. Anal intraepithelial neoplasia: diagnosis, screening, and treatment
9
Seminars in Colon and Rectal Surgery. High-resolution anoscopy: Procedure and findings
10
PubMed. An integrative review of guidelines for anal cancer screening in HIV-infected persons
11
Clinical Infectious Diseases. Screening HIV-Infected Individuals for Anal Cancer Precursor Lesions: A Systematic Review
12
PubMed Central. An Updated Review on Imaging and Staging of Anal Cancer—Not Just Rectal Cancer
13
Wiley Online Library (Cancer Medicine). Risk of cancer in patients with fecal incontinence